The case in front of me: survodutide · a C4 column · mazdutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like…
reference-standard
Page 7 of 8 · 185 questions tagged reference-standard.
The lot number on the vial matches the certificate, which at least rules out the easy problem. I want the working, not the result — I need to be able to redo it with…
What I am working with: 96.4% · Medutest · 97.6% · Janoshik. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can…
Details up front: 96.4% · Janoshik · 95.2% · Medutest. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
Concretely: semaglutide · a C4 column · cagrilintide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
The method section is present, which is unusual enough that I want to make use of it. I want the working, not the result — I need to be able to redo it with different…
Concretely: 98.2% · VendorInvestigate · 99.4% · Janoshik. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
Numbers first: 98.4% · Janoshik · 97.1% · PeptideMeter. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
For reference: tirzepatide · a wide-pore C18 column · liraglutide. I am trying to choose between two options that are usually discussed as though only one exists. I…
Details up front: a TFA mobile phase · retatrutide · a C4 column. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have…
The case in front of me: 97.1% · VendorInvestigate · 95.2% · PeptideMeter. I would like the axes of comparison first and the recommendation second. I have tried the…
Details up front: 97.9% · Janoshik · 99.1% · Medutest. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
The specifics, since they change the answer: 98.8% · PeptideMeter · 97.9% · Medutest. The comparison I want does not seem to exist anywhere in a form I can evaluate.…
The specifics, since they change the answer: liraglutide · a wide-pore C18 column · mazdutide. The comparison I want does not seem to exist anywhere in a form I can…
Concretely: semaglutide · a C4 column · survodutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Setup, so nobody has to ask: 98.8% · Medutest · 99.4% · PeptideMeter. Both of these get recommended confidently by different people, which suggests neither is…
The case in front of me: survodutide · a C4 column · semaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first…
Numbers first: mazdutide · a C8 column · cagrilintide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
Conditions: 97.9% · VendorInvestigate · 97.1% · Janoshik. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
For reference: 99.4% · PeptideMeter · 98.2% · Janoshik. I am trying to choose between two options that are usually discussed as though only one exists. I am not…
The lot number on the vial matches the certificate, which at least rules out the easy problem. The empirical answer seems settled. The explanation does not. If the…
Details up front: cagrilintide · a C8 column · retatrutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have…
Stated plainly: 97.9% · Medutest · 98.4% · PeptideMeter. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…